Molecular and Cellular Biology, September 2001, p. 6198-6209, Vol. 21, No. 18
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.18.6198-6209.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Infectious Diseases Research, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285
Received 1 May 2001/Returned for modification 4 June 2001/Accepted 25 June 2001
| |
ABSTRACT |
|---|
|
|
|---|
Sphingolipids are major components of the plasma membrane of eukaryotic cells and were once thought of merely as structural components of the membrane. We have investigated effects of inhibiting sphingolipid biosynthesis, both in germinating spores and growing hyphae of Aspergillus nidulans. In germinating spores, genetic or pharmacological inactivation of inositol phosphorylceramide (IPC) synthase arrests the cell cycle in G1 and also prevents polarized growth during spore germination. However, inactivation of IPC synthase not only eliminates sphingolipid biosynthesis but also leads to a marked accumulation of ceramide, its upstream intermediate. We therefore inactivated serine palmitoyltransferase, the first enzyme in the sphingolipid biosynthesis pathway, to determine effects of inhibiting sphingolipid biosynthesis without an accumulation of ceramide. This inactivation also prevented polarized growth but did not affect nuclear division of germinating spores. To see if sphingolipid biosynthesis is required to maintain polarized growth, and not just to establish polarity, we inhibited sphingolipid biosynthesis in cells in which polarity was already established. This inhibition rapidly abolished normal cell polarity and promoted cell tip branching, which normally never occurs. Cell tip branching was closely associated with dramatic changes in the normally highly polarized actin cytoskeleton and found to be dependent on actin function. The results indicate that sphingolipids are essential for the establishment and maintenance of cell polarity via control of the actin cytoskeleton and that accumulation of ceramide is likely responsible for arresting the cell cycle in G1.
| |
INTRODUCTION |
|---|
|
|
|---|
Sphingolipids are ubiquitous components of eukaryotic cell membranes and are particularly enriched in the plasma membrane. In Saccharomyces cerevisiae, sphingolipids account for 30% of total phospholipids of the plasma membrane (32). The sphingolipid biosynthesis pathway has been well characterized in many organisms, and many genes in this pathway have also been cloned (7). Sphingolipids are composed of a long-chain sphingoid base normally 18 carbons long with an amide linkage to a fatty acid at the 2-amino group and with various polar additions to the 1-hydroxyl group. The synthesis of the long-chain base component of sphingolipids begins with the condensation of serine and palmitoyl coenzyme A (CoA) to yield 3-ketosphinganine. The 3-ketosphinganine is reduced to form the long-chain base sphinganine, which is N-fatty-acid acylated to yield dihydroceramide. In animals, dihydroceramide is oxidized to ceramide by the introduction of a trans-4,5 double bond. In fungi sphinganine is hydroxylated on C-4 to form phytosphinosine before N-fatty-acid acylation to form phytoceramide. Ceramide is then rapidly converted to sphingomyelin by the addition of phosphocholine in animals or converted to inositol phosphorylceramide (IPC) by the addition of myo-inositol phosphate in fungi. Sphingolipids are subsequently further modified by addition of various sugars and sometimes sulfates to form a large number of complex sphingolipids. Three major species of sphingolipids are found in S. cerevisiae, that is, IPC, mannose-inositol-P-ceramide, and mannose-(inositol-P)-2-ceramide (7).
Previously considered to play mainly a structural role in membranes, the sphingolipid metabolic pathway is now recognized as an important signaling system conserved from fungi to humans. Metabolites derived from the breakdown of complex sphingolipids, or sometimes from de novo synthesis, are found to be highly bioactive molecules that are implicated as second messengers mediating diverse cellular functions. The metabolite that has been studied most extensively is ceramide, a central component of the sphingolipid pathway. Ceramide is not only a building block for sphingolipid synthesis but also a source for other bioactive molecules, such as sphingosine and sphingosine-1-phosphate (11, 22). A role for ceramide in various stress responses is now well established in many biological systems, including the heat shock response of S. cerevisiae (11, 17, 22, 39). A large number of stress agents are shown to transiently regulate sphingolipid metabolism and cause ceramide to accumulate. Moreover, increasing cellular levels of ceramide experimentally has been shown to be sufficient to induce many of the stress responses, including cell cycle arrest and apoptosis, that are normally associated with the treatment of stress agents (11, 22).
In addition to being a particularly rich source of highly bioactive metabolites, sphingolipids, as major components of membranes with so many distinct species in any given cell type, may have many, still unknown, physiological and cellular functions. Indeed, a genetic study of S. cerevisiae showed that sphingolipids are in fact essential for growth, even under nonstressful conditions (27). Furthermore, no significant turnover of complex sphingolipids has been observed in S. cerevisiae in response to any stress. Rather, accumulation of ceramide normally comes from de novo synthesis (17, 39). Thus, complex sphingolipids are directly required for growth in S. cerevisiae. How sphingolipids are required for yeast growth is not understood.
Aspergillus nidulans, a filamentous fungus, is a genetically tractable model organism well suited and widely used to study cell cycle regulation, polarized hyphal cell growth, and development in fungi (2, 26). To study the biological functions of sphingolipids, we analyzed the cellular consequences of inactivation of serine palmitoyltransferase (SPT) and IPC synthase using A. nidulans as a model system. SPT and IPC synthase are two rate-limiting enzymes in the sphingolipid biosynthesis pathway (7). SPT catalyzes the first committed step of sphingolipid biosynthesis, the formation of 3-ketosphinganine through condensation of serine and palmitoyl-CoA. IPC synthase catalyzes the addition of myo-inositol phosphate to the 1-hydroxy group of ceramide to produce IPC. In this study we uncovered a novel role of sphingolipids in cell polarity by regulating polarized organization of the actin cytoskeleton. In addition, we provide evidence demonstrating that IPC synthase plays an important role in mediating the level of cellular ceramide and that ceramide regulates cell cycle progression through G1.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Strains and general techniques.
A. nidulans
strains used in this study were the A773 strain (pyrG89
pyroA4 wA1); SO182 (nimT23 pyrG89 pabaA1
chaA1); a strain containing an aurA gene with a
mutation producing a G275V change (the
aurAG275V-10 strain)
(pyrG89 pyroA4 aurAG275V
aurA+ pyrG+
wA1); the pyrG strain (pyrG89 pyroA4
pyrG+ wA1); the
aurA3
-15, -18, and -30
strains (pyrG89 pyroA4 alcA::aurA aurA3'
pyrG+ wA1); JCC152-19
(pyrG89 pyroA4 nimT23 alcA::aurA
aurA3'
pyrG+ wA1); and the
lcbA3
-263, -326, and
-327 strains (pyrG89 pyroA4 alcA::lcbA pyrG+
lcbA3'
wA1). Media and general techniques for
culture, transformation, and genetic crossing of Aspergillus
strains were as previously described (41). The
nimT23 block-release experiment,
4',6'-diamidino-2-phenylindole (DAPI; Sigma, St. Louis, Mo.) staining,
a hydroxyurea (HU) S-phase block, and nocodazole (Sigma) treatment for
chromosome mitotic index (CMI) determination were also carried out as
previously described (41). Cytochalasin A (CcA;
Sigma) treatment to depolymerize the actin cytoskeleton was as
described previously (36). Aureobasidin A (AbA) and
myriocin (Sigma) were dissolved in ethanol at 10 and 5 mg per ml,
respectively, and added into medium to the final concentrations
indicated in Results. The S. cerevisiae strain used in this
study was YPH499 (MATa ura3-52
lys2-801amber
ade2-101ochre
trp1
63 his3
200
leu2
1) from Stratagene (La Jolla, Calif.), and
the yeast cells were grown in inositol-free synthetic complete medium.
Labeling and analysis of sphingolipids. Pulse-labeling of sphingolipids with [2-3H]inositol and [4,5-3H] dihydrosphingosine ([4,5-3H]DHS) were performed as described previously (12). Briefly, cells were grown to early exponential phase (107/ml) and pulse-labeled with [3H]inositol (5 µCi/ml) for 60 min or with 10 µM [3H]DHS (2 µCi/ml) for 60 min in 10-ml cultures of inositol-free medium. Cells were harvested by centrifugation (3,000 × g) and treated with 5% cold trichloroacetic acid on ice for 60 min. Lipids were extracted using the 95% ethanol-water-diethylether-pyridine-ammonium hydroxide (15:15:5:1:0.018 [vol/vol/vol/vol]) solvent system. Extracted lipids were dried under nitrogen. Monomethylamine reagent (methanol-water-butanol-methylamine, 4:3:1:5 [vol/vol]) was added to dried extract, which was then incubated at 52°C for 30 min to deacylate the lipids. The mixture was dried under nitrogen and resuspended in 0.2 ml of chloroform-methanol-H2O (16:16:5). Radiolabeled lipids were then separated on Silica Gel 60 thin-layer chromatography (TLC) plates (EM Merck) using chloroform-methanol-4.2 N ammonium hydroxide (9:7:2 [vol/vol/vol]) and visualized on a Molecular Dynamics Typhoon PhosphorImager by using a tritium-sensitive phosphor screen.
Determination of IPC synthase activity. IPC synthase activity was measured by monitoring the incorporation of N-[(7-nitrobenz-2-oxa-1,3-diazol-4-yl) aminocaproyl] (NBD)-C6-ceramide (Molecular Probes, Eugene, Oreg.) into chloroform soluble NBD-IPC in a mixed micellar assay system (9). Microsomes were prepared from homogenized A. nidulans cells (10 g [wet weight]) by differential centrifugation. Chloroform-soluble NBD-IPC was analyzed by TLC on Silica Gel 60 plates (EM Science) using the chloroform-methanol-water (65:24:4 [vol/vol/vol]) solvent system. NBD-IPC was quantified by direct fluorescence using a Molecular Dynamics Typhoon imager.
aurA disruption.
An aurA
disruption construct was made by three-step cloning using pBluescript
II SK(+) (Stratagene). A 2,018-bp 5'-end-flanking sequence was
amplified from A. nidulans genomic DNA by PCR using a pair
of primers, ATAAGAATGCGGCCGCTCTGTGGCTTCCGGTTGGCTAC and GCTCTAGACCAGGGTTGAGTCGGCAGCATG, and cloned into the
NotI and XbaI sites of pBluescript II sk(+). The
3,130-bp 3'-end-flanking sequence was amplified in the same manner
using the primers CGGGATCCTGAAGCCCGTCTTCGTGACC and
GAGCAGATATCGGTGGTCCAAATACAGGTACC and cloned into the
BamHI and EcoRV sites. Finally, a 1,892-bp
A. fumigatus pyrG fragment (38) was cloned into
the XbaI and BamHI sites as an XbaI
and BglII fragment to give rise to pAURA
, in which the
aurA open reading frame (ORF) was disrupted and the sequence
from Ala297 to Met308 was
replaced by pyrG of A. fumigatus.
was
used to replace aurA by transformation of the A773 strain.
Transformants were screened for heterokaryons on selective yeast
extract-glucose-agar plates as previously described
(42). Suspected heterokaryons were maintained as mycelial
colonies on the selective medium. PCR analysis of the selected
heterokaryons was carried out to confirm aurA disruption
using a primer specifically derived from pyrG of A. fumigatus and a primer derived from sequences from the
aurA locus further upstream or downstream of the sequences used to construct pAURA
.
lcbA cloning. The lcbA gene of A. nidulans was cloned by rapid amplification of cDNA ends (RACE)-PCR based on a 300-bp expressed sequence tag (g4a07a1.r1) from the Fungal Genetic Stock Center A. nidulans cDNA database (http://www.genome.ou.edu/asper_blast.html), which was identified by homology search using LCB1 of S. cerevisiae. Aspergillus mycelia grown in yeast extract-glucose to early log phase were harvested. After snap-freezing in liquid nitrogen, the mycelia were lyophilized. The lyophilized mycelia were ground to a fine powder using a mortar and pestle, and total RNA was isolated using TRIzol reagent (GIBCO BRL, Rockville, Md.). The mRNA was then purified from the total RNA using the PolyATtract mRNA isolation system (Promega, Madison, Wis.). Adapter-ligated cDNA was synthesized, and the subsequent RACE-PCR was carried out using the Marathon cDNA amplification kit (Clontech, Palo Alto, Calif.) according to the manufacturer's instructions. The 5' and 3' RACE primers used were CGAAAGCTGGACGACACCAGGCTTGG and GCCTGCGCAGCGTGTGCGCTATTGCTG, respectively. After the first round of PCR, the DNA was further amplified by a second round of PCR using nested primers: TACTTCGGGGCGAGCAAATAGCGG for the 5' RACE and TATGTGAAGTCTAGCTACCAGAATG for the 3' RACE. The specific PCR products were separated by electrophoresis on low-melting-temperature gels, excised, cloned into the vector pCR2.1 (Invitrogen), and sequenced. The assembled full-length cDNA contains a 497-amino-acid (aa) ORF whose deduced amino acid sequence shows high homology to LCB1. This gene is thus designated lcbA according to A. nidulans gene naming conventions.
Generation of alcA::aurA-
and alcA::lcbA-dependent
strains.
To create an alcohol-dependent aurA strain, we
cloned a 1,290-bp fragment of aurA with a 3' 159-aa
truncation under the control of the alcA promoter, which is
alcohol inducible and glucose repressible (37), into
pBluescript II sk(+), with the pyrG gene of A. fumigatus as a selection marker. The resulting plasmid was
designated pAURA3'
. The circular pAURA3'
DNA was used to
transform the A773 strain. A single homologous recombination of
pAURA3'
at the endogenous aurA locus would result in 3'
truncation of the endogenous aurA gene and, at the same
time, a full-length aurA gene under the control of the
alcA promoter. The transformants were first screened for
heterokaryons on selective YAG plates. Selected heterokaryons were then
further tested for dependence on medium containing alcohol as the sole
carbon source for growth. Alcohol-dependent strains were then analyzed
by PCR as described above for aurA deletion. An
alcohol-dependent lcbA strain was also generated in the same manner with a construct containing a 3' truncation of 215 aa of the
product of lcbA.
Indirect immunofluorescence staining of microtubules, actins, and nucleoli. The procedures for indirect immunofluorescence staining of microtubules, actins, and nucleoli in A. nidulans were as described previously (41). A mouse monoclonal antitubulin antibody, B5-1-2, (Sigma) was used at a 1:200 dilution to stain microtubules. A mouse monoclonal antiactin antibody, Ab-1 (Oncogene), was used at a 1:5,000 dilution to stain actin, and the human autoantibody ANA-N (Sigma) was used to stain nucleoli at a 1:4 dilution. The secondary antibody, goat anti-mouse immunoglobulin G conjugated with fluorescein isothiocyanate (F2653; Sigma), was used at a 1:200 dilution in actin and tubulin staining, and the secondary antibody, goat anti-human immunoglobulin G conjugated with fluorescein isothiocyanate (F3512; Sigma), was used at a 1:64 dilution in nucleolar staining.
Nucleotide sequence accession number. The nucleotide sequence of the lcbA gene has been deposited in GenBank under accession number AY032867.
| |
RESULTS |
|---|
|
|
|---|
aurA function is essential for sphingolipid biosynthesis and growth in A. nidulans The aurA gene of A. nidulans was cloned with a dominant mutation producing resistance to the antifungal compound AbA (18). Sequence homology suggests that aurA is a homolog of AUR1 of S. cerevisiae, which was also cloned originally as a mutated gene that produces resistance to AbA (14, 16). AUR1 has been shown to be required for IPC synthase activity, and thus AUR1 is thought to encode IPC synthase or an essential subunit of IPC synthase in S. cerevisiae (27). To see if aurA is also required for IPC synthase activity in A. nidulans, we first assayed IPC synthase activity in early-log-phase A. nidulans cells. Exponentially growing yeast cells were used as a positive control. Compared to yeast cells, surprisingly, actively growing A. nidulans cells contain very little IPC synthase activity (data not shown).
It is possible that A. nidulans IPC synthase requires some unknown factors for activity or that the assay conditions optimized for the yeast IPC synthase are not suitable for the A. nidulans IPC synthase. To circumvent these potential problems, we detected IPC synthase activity by monitoring the incorporation of [3H]myo-inositol into sphingolipids in the presence and absence of the IPC synthase inhibitor AbA. As shown in Fig. 1A, both A. nidulans and yeast cells efficiently incorporated the labeled inositol into sphingolipids. Although A. nidulans produces different sphingolipid species, sphingolipid synthesis in both yeast and A. nidulans was equally inhibited by AbA. To determine whether inhibition of sphingolipid synthesis by AbA is specific to inactivation of AURA function, we recreated the dominant resistance mutation (G275V) by in vitro mutagenesis and then introduced the mutant aurA gene into A. nidulans cells by transformation. A. nidulans cells carrying aurA with the mutation producing the G275V change became highly resistant to AbA (Fig. 1B). Furthermore, sphingolipid synthesis in the AbA resistance cells was not significantly inhibited by AbA (Fig. 1A). The results thus indicate that the aurA gene of A. nidulans, like the AUR1 gene of S. cerevisiae, is required for IPC synthase activity.
|
|
Inactivation of AURA causes cell cycle arrest in
G1.
To determine whether AURA indeed has a role in
cell cycle progression, we analyzed the kinetics of entry into the
first mitosis in germinating spores in the presence or absence of AURA
as spores entered the cell cycle uniformly from
G1. To better monitor the kinetics of entry into
mitosis, we included nocodazole, a microtubule poison, in the
germinating medium to trap cells in a mitotic state as cells progressed
into mitosis. In glycerol-containing medium, both
alcA::aurA-dependent and wt strains
entered into the first mitosis with similar kinetics, with the mitotic
index peaking 8.5 h after germination (Fig.
3A). By contrast, in the
glucose-containing (repressing) medium, the
alcA::aurA-dependent strain showed a marked delay in entry into mitosis, as its mitotic index did not peak
until 7 h, while the wt strain had a peak mitotic index 6 h
after germination (Fig. 3B). Similarly, addition of 5 µg of AbA per
ml in the medium to inactivate AURA also markedly delayed entry into
mitosis (Fig. 3C), thus implicating an important role for AURA in cell
cycle progression.
|
|
|
AURA is required for polarized hyphal growth via regulation of the
actin cytoskeleton.
As shown in Fig. 2, inactivation of AURA
inhibited polarized growth of germinating spores, suggesting a
potential role of AURA in cell polarity. Upon germination, A. nidulans spores undergo highly polarized growth through tip
extension, giving rise to long tubular structures called hyphae. Hyphal
branching occurs usually several cells posterior to the hyphal tip and
never occurs at the tip. To better understand how AURA may regulate
polarized hyphal growth, we first let spores germinate to form small
hyphae before inactivating AURA. As expected, control hyphae grow in a
highly polarized fashion, and no hyphal tip branching was observed (Fig. 6A). By contrast, inactivation of
AURA by either shutting off aurA expression from
alcA or by addition of AbA rapidly inhibited polarized
hyphal growth and subsequently promoted multiple branching at or near
the hyphal tips (Fig. 6A). The treated hyphae became abnormally wide
compared to those of the control. These dramatic morphogenic changes
were specifically caused by inactivation of AURA, as the AbA-resistant
mutant cells continued polarized growth in the presence of AbA.
|
Sphingolipids are required for hyphal polarity, and accumulation of
ceramide is associated with G1 arrest.
In S. cerevisiae, inactivation of IPC synthase activity not only
inhibits sphingolipid synthesis but also leads to accumulation of the
upstream intermediate, ceramide (27), which is thought to
play a regulatory role in a wide range of cellular activities (11, 22). To differentiate whether defects in the cell
cycle and hyphal polarity of cells lacking AURA are caused by
inhibition of sphingolipid synthesis or by accumulation of ceramide, we
analyzed the effects of myriocin, a specific inhibitor of SPT
(24). SPT catalyzes the first committed step in
sphingolipid biosynthesis. We reasoned that if defects in the cell
cycle and cell polarity in the absence of AURA function are caused by
the inhibition of sphingolipid synthesis, but not by the accumulation
of ceramide, then inactivation of SPT, which abolishes the entire
sphingolipid biosynthesis pathway, would exactly phenocopy AURA
inactivation. Indeed, pharmacological inactivation of SPT with myriocin
prevented polarized growth of germinating spores (Fig.
7A, panel a). Moreover, addition of
myriocin to germlings, as in the experiment described in the legend to
Fig. 6, promoted hyphal tip branching exactly as occurred after AbA
treatment (Fig. 7A, panel c). The data thus show that polarity defects
in cells lacking AURA function were caused by inhibition of
sphingolipid biosynthesis, indicating an important role of
sphingolipids in hyphal polarity.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
Sphingolipids are major components of the plasma membranes of eukaryotic cells and are shown to be essential for growth in S. cerevisiae (27). Although much is known about the sphingolipid biosynthetic pathway and the importance of sphingolipid metabolites as second messengers in signal transduction, little work has been directed towards investigating the direct biological functions of sphingolipids. In this study we characterized the function of aurA and lcbA in A. nidulans and showed that they are functional homologs of S. cerevisiae AUR1 and LCB1, respectively. AUR1 is required for IPC synthase activity, and LCB1 encodes a subunit of serine palmitoyl-CoA transferase (5). The present study provides strong evidence for an important role of IPC synthase in cell cycle progression through G1 and for the essentiality of sphingolipids for hyphal cell polarity in A. nidulans.
Several lines of evidence indicate that IPC synthase activity is required for cell cycle progression through G1 phase. First, inactivation of IPC synthase in germinating spores, which enter the cell cycle from a natural resting state in G1, caused a marked delay in progression of the first cell cycle. Cells were then terminally arrested after one round of nuclear division with two small nuclei, most likely in G1. However, when germinating spores were first allowed to progress through G1 and then arrested in G2 or early S phase prior to inactivation of IPC synthase, then this delay in progression of the first cell cycle was abolished. Second, results from nimT23cdc25 block-release experiments showed that, upon release from nimT23cdc25 G2 arrest, the cell cycles of cells lacking IPC synthase activity were arrested immediately after progression through a normal mitosis. These arrested cells contained interphase microtubule arrays and two small nuclei devoid of nucleoli, consistent with G1 arrest. Third, cell cycle arrest caused by inactivation of IPC synthase was associated with a marked increase in levels of cellular ceramide. In fact, accumulation of cellular ceramide is likely responsible for the G1 arrest. This supposition is supported by the observation that inactivation of SPT activity, which eliminated the entire sphingolipid synthesis pathway, including ceramide synthesis, produced all the phenotypes associated with IPC synthase inactivation, except for cell cycle arrest. Additionally, in S. cerevisiae an increase in the level of cellular ceramide caused by overexpression of YSR2, a DHS-1-phosphate phosphatase, is associated with a G1 delay of the cell cycle (21). Furthermore, treatment of S. cerevisiae cells with a synthetic ceramide causes cell cycle arrest in G1, which is further shown to be mediated through a ceramide-activated protein phosphatase (28).
Our present results strongly suggest that IPC synthase plays a pivotal role in mediating the level of cellular ceramide. Ceramide is implicated as a second messenger in stress responses (11, 22). In normal growing cells the level of cellular ceramide remains very low. Upon stress treatments such as heat shock, the level of cellular ceramide is rapidly and transiently increased. In S. cerevisiae, the increase in cellular ceramide upon heat shock is due to de novo synthesis (17, 39). In A. nidulans, heat shock rapidly and transiently inhibits both cell growth and nuclear division (43). Progression of the cell cycle needs to be tightly coupled to cell growth. Perhaps IPC synthase helps couple the cell cycle to growth during stress responses in fungi, as sphingolipid biosynthesis is required for cell growth and increases in amounts of cellular ceramide cause G1 arrest. In this scenario, heat shock or other stresses would rapidly and transiently inhibit IPC synthase activity, which stops sphingolipid biosynthesis and simultaneously leads to the accumulation of the upstream intermediate, ceramide. Inhibition of sphingolipid biosynthesis would prevent cell growth, and accumulation of ceramide would coordinately inhibit cell cycle progression, thus coupling the cell cycle to growth to allow successful adaptation of cells to stress conditions.
A. nidulans produces uninucleate conidiospores that germinate to form hyphal cells. Germinating spores employ two distinct modes of growth. They first grow isotropically, by adding new cell wall material uniformly in all directions. Following the first nuclear division, germinating spores then switch to polarized growth to form a germ tube. Subsequent hyphal growth is highly polarized, occurring exclusively at the tip of the germ tube and thus giving rise to a tubular hyphal filament. Here we showed that sphingolipids are required for both the establishment and the maintenance of hyphal cell polarity. Inhibition of sphingolipid biosynthesis by inactivation of IPC synthase or SPT in germinating spores allowed isotropic spore cell expansion but prevented subsequent polarized growth. This phenotype was particularly striking in germinating spores lacking SPT function. In the absence of SPT function, spores continued isotropic growth and nuclear division before eventually collapsing due to plasmolysis. Plasmolysis is likely to be caused by defects in the plasma membrane, as sphingolipids are its major components. Unlike spores lacking SPT function, germinating spores with inactive IPC synthase do not continue isotropic growth and nuclear division after an initial isotropic expansion and one round of nuclear division. The phenotypic differences between spores lacking SPT function and those lacking IPC synthase function can be explained by the fact that inactivation of IPC synthase causes marked accumulation of ceramide. Ceramide is highly bioactive and known to cause rapid cell cycle arrest or cell death in many organisms (11, 22).
Sphingolipids are also required for the maintenance of hyphal cell polarity, as inhibition of sphingolipid biosynthesis in germlings rapidly inhibited the normal polarized hyphal growth and consequently hyphal cells became abnormally wide. Interestingly, multiple short branches were subsequently initiated at or near the hyphal tip, further indicating that the normal hyphal cell polarity was abolished in the absence of sphingolipid biosynthesis. Hyphal tip branching never occurs in wt cells, and hyphal branches are initiated invariably several cells posterior to the hyphal tip.
Several genes required for the establishment of hyphal cell polarity have been identified recently from a collection of temperature-sensitive mutants of A. nidulans (13, 25). Temperature shift experiments further show that some of the genes are also required for the maintenance of hyphal cell polarity. Although these genes have not been cloned, judging from the phenotypes suppressible by high-level-osmosis medium (25), most of them may function in the Rho1-Pkc1-mediated cell wall integrity signaling pathway. This assumption is in agreement with the report that in A. nidulans deletion of mpkA, a component of the cell wall integrity pathway, results in similar defects in hyphal cell polarity and cell lysis, both suppressible by high-level-osmosis growth medium (6). As defects in cell polarity caused by inhibition of sphingolipid biosynthesis are not suppressible by high-level osmolarity (J. Cheng and X. Ye, unpublished observation), this indicates that sphingolipids do not mediate hyphal cell polarity through the cell wall integrity signaling pathway.
Polarized cell growth requires the polarized organization of the actin cytoskeleton in fungi. Actin immuno-staining showed that the actin cytoskeleton of the growing hyphae is normally organized in a highly polarized fashion. The actin patches are highly enriched towards the hyphal tip and form a discrete, intensely stained band right behind the growing tip. Inhibition of sphingolipid biosynthesis rapidly disrupts this pattern of actin organization, concomitant with the cessation of the normal polarized hyphal growth and clearly preceding the emergence of multiple short hyphal branches at or near the hyphal tip. These observations clearly demonstrate that sphingolipids are required for the polarized organization of the actin cytoskeleton, thus providing a molecular basis for their role in hyphal cell polarity.
Sphingolipids do not appear to be required for all functions of the actin cytoskeleton, however. For instance, in the absence of sphingolipid biosynthesis, the actin ring associated with septation formed normally, even several hours after the polarized organization of the actin cytoskeleton had been abolished. Additionally, the emergence of each hyphal branch at or near the hyphal tip in the absence of sphingolipid biosynthesis was always associated with an actin aggregate and required the actin function, as addition of CcA completely prevented branch emergence. This indicates that sphingolipids do not play a general role in actin function but are specifically required for the polarized organization of the actin cytoskeleton.
A role for sphingolipids in cell morphogenesis appears to be conserved in fungi. It is shown that inhibition of sphingolipid synthesis also causes marked changes in the morphology of S. cerevisiae and Schizosaccharomyces pombe cells, consistent with defects in polarized growth (8, 10, 14, 15, 44). However, whether the morphological defects of the yeast cells in the absence of sphingolipid synthesis also result from defects in the polarized organization of their actin cytoskeletons, like in A. nidulans shown in this study, remains to be established. While the effect of inhibiting sphingolipid synthesis on actin organization in S. pombe was not investigated (15), conflicting results on the effect of inhibiting sphingolipid synthesis on actin organization in S. cerevisiae were reported by the same group in two different studies (8, 14). Inactivating IPC synthase by promoter rundown from GAL1 promoter-controlled AUR1 showed no effect on the actin cytoskeleton organization, although cellular microtubules were completely depolymerized in the cells (14). On the other hand, treatment of S. cerevisiae cells with AbA to inactivate IPC synthase caused marked changes in the polarized distribution of cortical actin patches and the depolymerization of actin cables (8). Recently it was reported that the loss of LCB1 activity in S. cerevisiae also causes marked defects in the polarized organization of the actin cytoskeleton, which results in the loss of endocytosis activity of the cells (10, 44). Interestingly, the defects in actin organization and endocytosis caused by the loss of LCB1 activity in S. cerevisiae can be corrected by the addition of sphingoid bases, even in the absence of sphingolipid synthesis (44), or by increased protein phosphorylation (10). However, as shown in this study, sphingolipids but not sphingoid bases are required for polarized organization of the actin cytoskeleton in A. nidulans. Inactivation of IPC synthase, which does not affect the synthesis of sphingoid bases, rapidly promoted a dramatic reorganization of the normally highly polarized actin cytoskeleton in the growing hyphae of A. nidulans.
The mechanism by which sphingolipids regulate polarized organization of the actin cytoskeleton in the growing hyphae of A. nidulans is not understood at present. Mounting evidence shows that eukaryotic cells contain sphingolipid and cholesterol-rich membrane domains, called lipid rafts. The function of lipid rafts is currently of tremendous interest to cell biologists (4, 35). The concept of lipid rafts originated from a study of epithelial cell polarity to explain how lipids and lipid-anchored proteins are selectively directed to different surfaces of polarized cells (34). Sphingolipids differ from other phospholipids in that they contain long and saturated acyl chains that readily pack tightly together. One of the most important properties of lipid rafts is the selective inclusion or exclusion of certain proteins (4, 35). Perhaps similar sphingolipid-rich plasma membrane domains exist at the hyphal tip regions in filamentous fungi and they have a high affinity for anchoring proteins of the actin cytoskeleton, hence the polarized organization of the actin cytoskeleton. It is also interesting that inactivation of myoA, which encodes an essential type I myosin, generates polarity defects in A. nidulans similar to those caused by inhibition of sphingolipid biosynthesis (23). The MYOA protein is also localized as patches in the hyphal tip region (40), as with actin localization. However, it has not been determined if MYOA and the actin cytoskeleton colocalize with each other. Recent studies of both budding and fission yeasts show that type I myosins stimulate Cdc42-dependent actin assembly through interactions with the Arp2-Arp3 complex (19, 20). Type I myosin has a lipid-binding domain in the tail region (1). Conceivably, the lipid-binding domain may help localize MYOA to the sphingolipid-rich hyphal tip region, where it promotes actin assembly.
In summary, we show here that IPC synthase is required for cell cycle progression through G1. We further show that IPC synthase plays an important role in mediating the level of cellular ceramide and that accumulation of ceramide is likely responsible for G1 arrest of cells lacking IPC synthase activity. Additionally, we demonstrate that sphingolipids are essential for cell polarity in A. nidulans through polarized organization of the actin cytoskeleton. Future studies will be aimed at elucidating the molecular mechanisms of ceramide-mediated G1 arrest and the requirement for sphingolipids in the polarized organization of the actin cytoskeleton.
| |
ACKNOWLEDGMENTS |
|---|
We thank Robert Dean for performing the initial IPC synthase activity assays. We also thank Jeff Radding and members of X. S. Ye's lab for valuable discussions during the course of this work and Sheng-bin Peng and Donald LeBlanc for critically reading the manuscript.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Infectious Diseases Research, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285. Phone: (317) 277-1467. Fax: (317) 277-0778. E-mail: Ye_Xiang{at}lilly.com.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Adams, R. J., and T. D. Pollard. 1989. Binding of myosin I to membrane lipids. Nature 340:565-568[CrossRef][Medline]. |
| 2. |
Adams, T. H,
J. K. Wieser, and J. H. Yu.
1998.
Asexual sporulation in Aspergillus nidulans.
Microbiol. Mol. Biol. Rev.
62:35-54 |
| 3. |
Bergen, L. G.,
A. Upshall, and N. R. Morris.
1984.
S-phase, G2, and nuclear division mutants of Aspergillus nidulans.
J. Bacteriol.
159:114-119 |
| 4. |
Brown, D. B., and E. London.
2000.
Structure and function of sphingolipid- and cholesterol-rich membrane rafts.
J. Biol. Chem.
275:17221-17224 |
| 5. |
Buede, R.,
C. Rinker-Schaffer,
W. J. Pinto,
R. L. Lester, and R. C. Dickson.
1991.
Cloning and characterization of LCB1, a Saccharomyces gene required for biosynthesis of the long-chain base component of sphingolipids.
J. Bacteriol.
173:4325-4332 |
| 6. | Bussink, H. J., and S. A. Osmani. 1999. A mitogen-activated protein kinase (MPKA) is involved in polarized growth in the filamentous fungus Aspergillus nidulans. FEMS Microbiol. Lett. 173:117-125[Medline]. |
| 7. | Dickson, R. C. 1998. Sphingolipid functions in Saccharomyces cerevisiae: comparison to mammals. Annu. Rev. Biochem. 67:27-48[CrossRef][Medline]. |
| 8. | Eno, M., K. Takesako, I. Kato, and H. Yamaguchi. 1997. Fungicidal action of aureobasidin A, a cyclic depsipeptide antifungal antibiotic, against Saccharomyces cerevisiae. Antimcriob. Agents Chemother. 41:672-676[Abstract]. |
| 9. | Fischl, A. S., Y. Liu, A. Browdy, and A. E. Cremesti. 2000. Inositolphosphoryl ceramide synthase from yeast. Methods Enzymol. 311:123-130[Medline]. |
| 10. | Friant, S., B. Zanolari, and H. Riezman. 2000. Increased protein kinase or decreased PP2A activity bypasses sphingoid base requirement in endocytosis. EMBO J. 19:2834-2844[CrossRef][Medline]. |
| 11. |
Hannun, Y. A.
1996.
Functions of ceramide in coordinating cellular responses to stress.
Science
274:1855-1859 |
| 12. | Hanson, B. A., and R. L. Lester. 1980. The extraction of inositol-containing phospholipids and phosphatidylcholine from Saccharomyces cerevisiae and Neurospora crassa. J. Lipid Res. 21:309-315[Abstract]. |
| 13. |
Harris, S. D.,
A. F. Hofmann,
H. W. Tedford, and M. P. Lee.
1999.
Identification and characterization of genes required for hyphal morphogenesis in the filamentous fungus Aspergillus nidulans.
Genetics
151:1015-1025 |
| 14. | Hashida-Okado, T., A. Ogawa, M. Endo, R. Yasumoto, K. Takesako, and I. Kato. 1996. AUR1, a novel gene conferring aureobasidin resistance on Saccharomyces cerevisiae: a study of defective morphologies in Aur1p-depleted cells. Mol. Gen. Genet. 251:236-244[Medline]. |
| 15. | Hashida-Okado, T., R. Yasumoto, M. Endo, K. Takesako, and I. Kato. 1998. Isolation and characterization of the aureobasidin A-resistant gene, aur1R, on Schizosaccharomyces pombe: role of Aur1p+ in cell morphogenesis. Curr. Genet. 33:38-45[CrossRef][Medline]. |
| 16. | Heidler, S. A., and J. A. Radding. 1995. The AUR1 gene in Saccharomyces cerevisiae encodes dominant resistance to the antifungal agent aureobasidin A (LY295337). Antimicrob. Agents Chemother. 39:2765-2769[Abstract]. |
| 17. |
Jenkins, G. M.,
A. Richards,
T. Wahl,
G. Mao,
L. Obeid, and Y. Hannun.
1997.
Involvement of yeast sphingolipids in the heat stress response of Saccharomyces cerevisiae.
J. Biol. Chem.
272:32566-32572 |
| 18. | Kuroda, M., T. Hashida-Okado, R. Yasumoto, K. Gomi, I. Kato, and K. Takesako. 1999. An aureobasidin A resistance gene isolated from Aspergillus is a homolog of yeast AUR1, a gene responsible for inositol phosphorylceramide (IPC) synthase activity. Mol. Gen. Genet. 261:290-296[CrossRef][Medline]. |
| 19. |
Lechler, T.,
A. Shevchenko,
A. Shevchenko, and R. Li.
2000.
Direct involvement of yeast type I myosins in Cdc42-dependent actin polymerization.
J. Cell Biol.
148:363-373 |
| 20. |
Lee, W. L.,
M. Bezanilla, and T. D. Pollard.
2000.
Fission yeast myosin-I, Myo1p, stimulates actin assembly by Arp2/3 complex and shares function with WASp.
J. Cell Biol.
151:789-799 |
| 21. | Mao, C., J. D. Saba, and L. M. Obeid. 1999. The dihydosphingosine-1-phosphate phosphatases of Saccharomyces cerevisiae are important regulators of cell proliferation and heat stress responses. Biochem. J. 342:667-675. |
| 22. | Mathias, S., L. A. Pena, and R. N. Kolesnick. 1998. Signal transduction of stress via ceramide. Biochem. J. 335:465-480. |
| 23. |
McGoldrick, C. A.,
C. Gruver, and G. S. May.
1995.
myoA of Aspergillus nidulans encodes an essential myosin I required for secretion and polarized growth.
J. Cell Biol.
128:577-587 |
| 24. | Miyake, Y., Y. Kozutsumi, S. Nakamura, T. Fujita, and T. Kawasaki. 1995. Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin. Biochem. Biophys. Res. Commun. 211:396-403[CrossRef][Medline]. |
| 25. |
Momany, M.,
P. J. Westfall, and G. Abramowsky.
1999.
Aspergillus nidulans swo mutants show defects in polarity establishment, polarity maintenance and hyphal morphogenesis.
Genetics
151:557-567 |
| 26. | Morris, N. R. 1989. The study of cytoskeletal proteins and mitosis using Aspergillus molecular genetics. Cell Motil. Cytoskeleton 14:58-61[CrossRef][Medline]. |
| 27. |
Nagiec, M. M.,
E. E. Nagiec,
J. A. Baltisberger,
G. B. Wells,
R. L. Lester, and R. C. Dickson.
1997.
Sphingolipid synthesis as a target for antifungal drugs: complementation of the inositol phosphorylceramide synthase defect in a mutant strain of Saccharomyces cerevisiae by the AUR1 gene.
J. Biol. Chem.
272:9809-9817 |
| 28. |
Nickels, J. T., and J. R. Broach.
1996.
A ceramide-activated protein phosphatase mediates ceramide-induced G1 arrest of Saccharomyces cerevisiae.
Genes Dev.
10:382-394 |
| 29. | Oakley, B. R., and S. A. Osmani. 1993. Cell-cycle analysis using the filamentous fungus Aspergillus nidulans, p. 127-142. In P. Fantes, and R. Brooks (ed.), The cell cycle, a practical approach. IRL Press, Oxford, United Kingdom. |
| 30. | O'Connell, M. J., A. H. Osmani, N. R. Morris, and S. A. Osmani. 1992. An extra copy of nimEcyclinB elevates pre-MPF levels and partially suppresses mutation of nimTcdc25 in Aspergillus nidulans. EMBO J. 11:2139-2149[Medline]. |
| 31. | Osmani, S. A., D. B. Engle, J. H. Doonan, and N. R. Morris. 1988. Spindle formation and chromatin condensation in cells blocked at interphase by mutation of a negative cell cycle control gene. Cell 52:241-252[CrossRef][Medline]. |
| 32. |
Patton, J. L., and R. L. Lester.
1991.
The phosphoinositol sphingolipids of Saccharomyces cerevisiae are highly localized in the plasma membrane.
J. Bacteriol.
173:3101-3108 |
| 33. | Rowland, R. R., R. Kervin, C. Kuckleburg, A. Sperlich, and D. A. Benfield. 1999. The localization of porcine reproductive and respiratory syndrome virus nucleocapsid protein to the nucleolus of infected cells and identification of a potential nucleolar localization signal sequence. Virus Res. 64:1-12[CrossRef][Medline]. |
| 34. | Simons, K., and G. van Meer. 1988. Lipid sorting in epithelial cells. Biochemistry 27:6197-6202[CrossRef][Medline]. |
| 35. | Simons, K., and D. Toomre. 2000. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell. Biol. 1:31-39[CrossRef][Medline]. |
| 36. | Torralba, S., M. Raudaskoski, A. M. Pedregosa, and F. Laborda. 1998. Effect of cytochalasin A on apical growth, actin cytoskeleton organization and enzyme secretion in Aspergillus nidulans. Microbiology 144:45-53[Abstract]. |
| 37. | Waring, R. B., G. S. May, and N. R. Morris. 1989. Characterization of an inducible expression system in Aspergillus nidulans using alcA and tubulin-coding genes. Gene 79:119-130[CrossRef][Medline]. |
| 38. | Weidner, G., C. d'Enfert, A. Koch, P. C. Mol, and A. A. Brakhage. 1998. Development of a homologous transformation system for the human pathogenic fungus Aspergillus fumigatus based on the pyrG gene encoding orotidine 5'-monophosphate decarboxylase. Curr. Genet. 33:378-385[CrossRef][Medline]. |
| 39. |
Wells, G. B.,
R. C. Dickson, and R. L. Lester.
1998.
Heat-induced elevation of ceramide in Saccharomyces cerevisiae via de novo synthesis.
J. Biol. Chem.
273:7235-7243 |
| 40. | Yamashita, R., N. Osherov, and G. S. May. 2000. Localization of wild type and mutant class I myosin proteins in Aspergillus nidulans using GFP-fusion proteins. Cell Motil. Cytoskeleton 45:163-172[CrossRef][Medline]. |
| 41. | Ye, X. S., R. R. Fincher, A. Tang, K. O'Donnell, and S. A. Osmani. 1996. Two S-phase checkpoint systems, one involving the functions of both BIME and tyr15 phosphorylation of p34cdc2, inhibit NIMA and prevent premature mitosis. EMBO J. 15:3599-3610[Medline]. |
| 42. |
Ye, X. S.,
R. R. Fincher,
A. Tang,
A. H. Osmani, and S. A. Osmani.
1998.
Regulation of the anaphase-promoting complex/cyclosome by bimAAPC3 and proteolysis of NIMA.
Mol. Biol. Cell
9:3019-3030 |
| 43. | Ye, X. S., G. Xu, R. R. Fincher, and S. A. Osmani. 1997. Characterization of NIMA protein kinase in Aspergillus nidulans. Methods Enzymol. 283:520-532[Medline]. |
| 44. | Zanolari, B., S. Friant, K. Funato, C. Sutterlin, B. J. Stevenson, and H. Riezman. 2000. Sphingoid base synthesis requirement for endocytosis in Saccharomyces cerevisiae. EMBO J. 19:2824-2833[CrossRef][Medline]. |
This article has been cited by other articles: